Raymon Durso, M.D. - Publications

Affiliations: 
Neurology Boston University School of Medicine, Boston, MA 
Area:
Parkinson's disease

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Morgan J, Clark D, Tripodis Y, Halloran CS, Minsky A, Wildman WJ, Durso R, McNamara P. Impacts of religious semantic priming on an intertemporal discounting task: Response time effects and neural correlates. Neuropsychologia. PMID 27450269 DOI: 10.1016/J.Neuropsychologia.2016.07.020  0.8
2016 Harris E, McNamara P, Durso R. Possible selves in patients with right- versus left-onset Parkinson's disease. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-18. PMID 27141970 DOI: 10.1080/13825585.2016.1178211  0.8
2015 Harris E, McNamara P, Durso R. Novelty seeking in patients with right- versus left-onset Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 28: 11-6. PMID 25812126 DOI: 10.1097/Wnn.0000000000000047  0.8
2014 Ratner MH, Farb DH, Ozer J, Feldman RG, Durso R. Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdisciplinary Toxicology. 7: 123-33. PMID 26109889 DOI: 10.2478/Intox-2014-0017  0.8
2013 Harris E, McNamara P, Durso R. Apathy in patients with Parkinson disease as a function of side of onset. Journal of Geriatric Psychiatry and Neurology. 26: 95-104. PMID 23584852 DOI: 10.1177/0891988713481267  0.8
2012 Modak A, Durso R, Josephs E, Rosen D. A rapid non invasive L-DOPA-¹³C breath test for optimally suppressing extracerebral AADC enzyme activity - toward individualizing carbidopa therapy in Parkinson’s disease. Journal of Parkinson's Disease. 2: 349-56. PMID 23646099 DOI: 10.3233/Jpd-012132  0.8
2011 Butler PM, McNamara P, Ghofrani J, Durso R. Disease-associated differences in religious cognition in patients with Parkinson's disease. Journal of Clinical and Experimental Neuropsychology. 33: 917-28. PMID 21656414 DOI: 10.1080/13803395.2011.575768  0.8
2011 Butler PM, McNamara P, Durso R. Side of onset in Parkinson's disease and alterations in religiosity: novel behavioral phenotypes. Behavioural Neurology. 24: 133-41. PMID 21606574 DOI: 10.3233/Ben-2011-0282  0.8
2010 McNamara P, Stavitsky K, Durso R, Harris E. The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates. Parkinson's Disease. 2010. PMID 20948889 DOI: 10.4061/2010/263083  0.8
2010 McNamara P, Holtgraves T, Durso R, Harris E. Social cognition of indirect speech: Evidence from Parkinson's Disease. Journal of Neurolinguistics. 23: 162. PMID 20161657 DOI: 10.1016/J.Jneuroling.2009.12.003  0.8
2010 Butler PM, McNamara P, Durso R. Deficits in the automatic activation of religious concepts in patients with Parkinson's disease. Journal of the International Neuropsychological Society : Jins. 16: 252-61. PMID 19958570 DOI: 10.1017/S1355617709991202  0.8
2010 Holtgraves T, McNamara P, Cappaert K, Durso R. Linguistic correlates of asymmetric motor symptom severity in Parkinson's Disease. Brain and Cognition. 72: 189-96. PMID 19751960 DOI: 10.1016/J.Bandc.2009.08.004  0.8
2010 McNamara P, Stavitsky K, Harris E, Szent-Imrey O, Durso R. Mood, side of motor symptom onset and pain complaints in Parkinson's disease. International Journal of Geriatric Psychiatry. 25: 519-24. PMID 19711336 DOI: 10.1002/Gps.2374  0.8
2008 Stavitsky K, McNamara P, Durso R, Harris E, Auerbach S, Cronin-Golomb A. Hallucinations, dreaming, and frequent dozing in Parkinson disease: impact of right-hemisphere neural networks. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 21: 143-9. PMID 18797256 DOI: 10.1097/Wnn.0B013E318185E698  0.8
2008 McNamara P, Durso R, Harris E. Alterations of the sense of self and personality in Parkinson's disease. International Journal of Geriatric Psychiatry. 23: 79-84. PMID 17562520 DOI: 10.1002/Gps.1845  0.8
2007 McNamara P, Durso R, Harris E. "Machiavellianism" and frontal dysfunction: evidence from Parkinson's disease. Cognitive Neuropsychiatry. 12: 285-300. PMID 17558639 DOI: 10.1080/13546800701202316  0.8
2006 McNamara P, Durso R, Brown A. Religiosity in patients with Parkinson's disease. Neuropsychiatric Disease and Treatment. 2: 341-8. PMID 19412480 DOI: 10.2147/Nedt.2006.2.3.341  0.8
2006 McNamara P, Durso R, Harris E. Life goals of patients with Parkinson's disease: A pilot study on correlations with mood and cognitive functions. Clinical Rehabilitation. 20: 818-26. PMID 17005505 DOI: 10.1177/0269215506070811  0.8
2006 McNamara P, Durso R. Neuropharmacological treatment of mental dysfunction in Parkinson's disease. Behavioural Neurology. 17: 43-51. PMID 16720959 DOI: 10.1155/2006/138263  0.8
2005 Wegelin J, McNamara P, Durso R, Brown A, McLaren D. Correlates of excessive daytime sleepiness in Parkinson's disease. Parkinsonism & Related Disorders. 11: 441-8. PMID 16154796 DOI: 10.1016/J.Parkreldis.2005.05.007  0.8
2005 Michaelides C, Thakore-James M, Durso R. Reversible withdrawal dyskinesia associated with quetiapine. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 769-70. PMID 15747370 DOI: 10.1002/mds.20427  0.8
2003 McNamara P, Durso R, Brown A. Relation of "Sense Of Self" to executive function performance in Parkinson's disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 16: 139-48. PMID 14501535 DOI: 10.1097/00146965-200309000-00001  0.8
2003 McNamara P, Durso R, Brown A, Lynch A. Counterfactual cognitive deficit in persons with Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 1065-70. PMID 12876235 DOI: 10.1136/Jnnp.74.8.1065  0.8
2003 McNamara P, Durso R. Pragmatic communication skills in patients with Parkinson's disease. Brain and Language. 84: 414-23. PMID 12662979 DOI: 10.1016/S0093-934X(02)00558-8  0.8
2002 McNamara P, Durso R, Auerbach S. Dopaminergic syndromes of sleep, mood and mentation: Evidence from Parkinson's disease and related disorders Sleep and Hypnosis. 4: 119-131.  0.8
2000 Durso R, Evans JE, Josephs E, Szabo G, Evans B, Fernandez HH, Browne TR. Variable absorption of carbidopa affects both peripheral and central levodopa metabolism. Journal of Clinical Pharmacology. 40: 854-60. PMID 10934669 DOI: 10.1177/00912700022009585  0.8
1998 Fernandez HH, Durso R. Clozapine for dopaminergic-induced paraphilias in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 597-8. PMID 9613761 DOI: 10.1002/Mds.870130338  0.8
1997 Durso R, Evans JE, Josephs E, Szabo GK, Evans BA, Handler JS, Jennings D, Browne TR. Central levodopa metabolism in Parkinson's disease after administration of stable isotope-labeled levodopa. Annals of Neurology. 42: 300-4. PMID 9307250 DOI: 10.1002/Ana.410420305  0.8
1997 Durso R. Chapter 17 Biotransformation and excretion: Quantitative studies of tissue metabolism Pharmacochemistry Library. 26: 315-335. DOI: 10.1016/S0165-7208(97)80164-X  0.8
1996 Krengel M, White RF, Diamond R, Letz R, Cyrus P, Durso R. A comparison of NES2 and traditional neuropsychological tests in a neurologic patient sample. Neurotoxicology and Teratology. 18: 435-9. PMID 8866535 DOI: 10.1016/0892-0362(96)00022-0  0.8
1996 McNamara P, Krueger M, O'Quin K, Clark J, Durso R. Grammaticality judgments and sentence comprehension in Parkinson's disease: a comparison with Broca's aphasia. The International Journal of Neuroscience. 86: 151-66. PMID 8828068 DOI: 10.3109/00207459608986706  0.8
1996 Folkerth RD, Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology. 46: 1219-25. PMID 8628456  0.8
1993 Durso R, Isaac K, Perry L, Saint-Hilaire M, Feldman RG. Age influences magnitude but not duration of response to levodopa. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 65-8. PMID 8429325  0.8
1992 McNamara P, Obler LK, Au R, Durso R, Albert ML. Speech monitoring skills in Alzheimer's disease, Parkinson's disease, and normal aging. Brain and Language. 42: 38-51. PMID 1547468 DOI: 10.1016/0093-934X(92)90055-J  0.8
1991 McNamara P, Durso R. Reversible pathologic jealousy (Othello syndrome) associated with amantadine. Journal of Geriatric Psychiatry and Neurology. 4: 157-9. PMID 1953968 DOI: 10.1177/089198879100400306  0.8
1990 Wolfe N, Katz DI, Albert ML, Almozlino A, Durso R, Smith MC, Volicer L. Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 53: 915-7. PMID 2266376 DOI: 10.1136/jnnp.53.10.915  0.8
1990 Fazzini E, Durso R, Davoudi H, Szabo GK, Albert ML. GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. Journal of the Neurological Sciences. 99: 59-68. PMID 2250172 DOI: 10.1016/0022-510X(90)90199-W  0.8
1990 Saint-Hilaire M, Feldman RG, Durso R. Deprenyl for the treatment of early Parkinson's disease (IV) New England Journal of Medicine. 322: 1527.  0.8
1989 Durso R, Szabo G, Davoudi H, Feldman RG. Magnitude of response to levodopa in Parkinson disease as it relates to peripheral and central measurements of levodopa and associated metabolites. Clinical Neuropharmacology. 12: 384-92. PMID 2611763 DOI: 10.1097/00002826-198910000-00003  0.8
1988 Szabo GK, Davoudi H, Durso R. High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization. Journal of Chromatography. 430: 112-7. PMID 3215947 DOI: 10.1016/S0378-4347(00)83139-4  0.8
1988 Rainero I, Kaye JA, May C, Durso R, Katz DI, Albert ML, Wolfe N, Pinessi L, Friedland RP, Rapoport SI. Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Archives of Neurology. 45: 1224-7. PMID 2847695 DOI: 10.1001/Archneur.1988.00520350062017  0.8
1983 Durso R, Tamminga CA, Ruggeri S, Denaro A, Kuo S, Chase TN. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 46: 1134-7. PMID 6229607 DOI: 10.1136/Jnnp.46.12.1134  0.8
1983 Durso R, Tamminga CA, Denaro A, Ruggeri S, Chase TN. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease. Neurology. 33: 1229-32. PMID 6225034 DOI: 10.1212/Wnl.33.9.1299  0.8
1982 Durso R, Fedio P, Brouwers P, Cox C, Martin AJ, Ruggieri SA, Tamminga CA, Chase TN. Lysine vasopressin in Alzheimer disease. Neurology. 32: 674-7. PMID 7201100 DOI: 10.1212/Wnl.32.6.674  0.8
1982 LeWitt PA, Gopinathan G, Ward CD, Sanes JN, Dambrosia JM, Durso R, Calne DB. Lisuride versus bromocriptine treatment in Parkinson disease: a double-blind study. Neurology. 32: 69-72. PMID 7033825 DOI: 10.1212/WNL.32.1.69  0.8
1982 Durso R, Tamminga CA, Chase TN. Neuroendocrine defects in Huntington disease Neurology. 32: A 142.  0.8
1982 Tamminga CA, Durso R, Fedio P, Chase TN. Vasopressin studies in Alzheimer's disease Psychopharmacology Bulletin. 18: 48-49.  0.8
1980 Lieberman AN, Kupersmith M, Neophytides A, Gopinathan G, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years. Advances in Biochemical Psychopharmacology. 23: 245-53. PMID 7395614  0.8
1980 Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Bear G, Goldstein M. Long-term efficacy of bromocriptine in Parkinson disease. Neurology. 30: 518-23. PMID 6768003  0.8
1979 Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Bromocriptine mesylate in Parkinson's disease. New York State Journal of Medicine. 79: 1689-92. PMID 290866  0.8
1979 Lieberman A, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T. Huntington's disease. New York State Journal of Medicine. 79: 1188-90. PMID 156887  0.8
1979 Lieberman A, Neophytides A, Kupersmith M, Casson I, Durso R, Foo SH, Khayali M, Tartaro T, Goldstein M. Treatment of Parkinson's disease with dopamine agonists: a review. The American Journal of the Medical Sciences. 278: 65-76. PMID 39452  0.8
Show low-probability matches.